| Total | Controls | Remote LTBI | Recent infection | Active TB | Cured TB | |
| Subjects n | 149 | 15 | 16 | 23 | 50 | 45 |
| Age yrs | 38.1±1.2 | 34.2±3.1 | 50.5±3.7 | 38.3±3.4 | 34.8±1.8 | 38.5±2.3 |
| Female sex | 69 (46.3) | 10 (66.7) | 4 (25.0) | 12 (52.2) | 21 (42.2) | 22 (48.9) |
| BCG vaccinated | 95 (63.8) | 6 (40.0) | 3 (18.3) | 14 (60.9) | 41 (82.0) | 31 (68.9) |
| Origin | ||||||
| Western Europe | 59 (39.6) | 12 (80.0) | 13 (81.3) | 9 (39.1) | 9 (18.0) | 16 (35.6) |
| Eastern Europe | 56 (37.6) | 2 (13.3) | 2 (12.5) | 9 (39.1) | 24 (48.0) | 19 (42.2) |
| Asia | 18 (12.1) | 1 (6.3) | 3 (13.0) | 10 (20.0) | 4 (8.9) | |
| Africa | 10 (6.7) | 2 (8.7) | 4 (8.0) | 4 (8.9) | ||
| Latin America | 6 (4.0) | 1 (6.7) | 3 (6.0) | 2 (4.4) | ||
| Confirmed TB localisation | ||||||
| Pulmonary | 41 (27.5) | 41 (82.0) | ||||
| Extrapulmonary | 5 (3.3) | 5 (10.0) | ||||
| Pulmonary and extrapulmonary | 4 (2.6) | 4 (8.0) | ||||
| TST mm | ND | 1±2.6 | 28.6±8.9 | 17.1±11.1 | ND | ND |
Data are presented as mean±sd or n (%), unless otherwise stated. LTBI: latent tuberculosis (TB) infection; BCG: bacille Calmette–Guérin; TST: tuberculin skin test; ND: not done.